GTBP

Wendel Bruce

CIK: 0001364846

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 11, 2026

GT Biopharma Files Prospectus for Up to 13.5M Shares. GT Biopharma Inc. has filed a prospectus that allows up to 13,502,835 shares of its common stock to be sold by existing shareholders. This filing gives the company and its investors a formal framework for a potential share sale. The prospectus does not change the company’s current operations or financial outlook. Investors can review the details to understand how the sale could affect share supply.

this person other insiders at GTBP

Transaction History

GTBP▲ Buy$0
GTBP▲ Buy$12K
GTBP▲ Buy$4K
GTBP▲ Buy$10K

We use analytics to understand how market-wall is used. No personal data is sold.